Antioxidative effects of novel synthetic organoselenium compound in rat lung and kidney

Ecotoxicology and Environmental Safety

Volumn 72, Issue 3, 2009, Pages 916-921

  Talas, Zeliha Selamoglu ^a   Ozdemir, Ilknur ^b   Yilmaz, Ismet ^b   Gok, Yetkin ^b  

^a NIGDE UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

DMBA; Kidney; Lung; Oxidative stress; Rat; Synthetic organoselenium compounds

Indexed keywords

1 ISOPROPYL 3 METHYLBENZIMIDAZOLE 2 SELENONE; 1,3 DI 4 METHOXYBENZYLPYRIMIDINE 2 SELENONE; CATALASE; DIMETHYLBENZ[A]ANTHRACENE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; ORGANOSELENIUM DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT; ENZYME ACTIVITY; MATURATION; ORGANIC COMPOUND; OXIDATION; RODENT; SELENIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; KIDNEY; LIPID PEROXIDATION; LUNG; NONHUMAN; OXIDATIVE STRESS; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTIOXIDANTS; BENZIMIDAZOLES; CATALASE; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; KIDNEY; LUNG; MALONDIALDEHYDE; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; PYRIMIDINES; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS; RATTUS NORVEGICUS;

EID: 59149083390     PISSN: 01476513     EISSN: 10902414     Source Type: Journal    
DOI: 10.1016/j.ecoenv.2007.11.012     Document Type: Article

References (44)

1. Arteel G.E., and Sies H. The biochemistry of selenium and the glutathione system. Environ. Toxicol. Pharmacol. 10 (2001) 153-158
2. 4Se. Anal. Sci. 19 (2003) 1093-1094
3. Beuge J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52 (1978) 302-310
4. Carlberg I., and Mannervik B. Glutathione reductase. Methods Enzymol. 113 (1985) 484-490
5. Carlo W.F., Hummer A.J., Schwartz L., Sullivan D., Gonen M., Jarnagin W., Fong Y., and Kemeny N. Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy. J. Surg. Oncol. 87 2 (2004) 85-90
6. Clark L.C., Combs G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher J.L., Park H.K., Sanders B.B., Smith C.L., and Taylor P.R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. J. Am. Med. Assoc. 276 (1996) 1957-1963
7. Clark L.C., Dalkin B., Krongrad A., Combs G.F., Turnbull B.W., Slate E.H., Witherington R., Herlong J.H., Janosko E., Carpenter D., Borosso C., Falk S., and Rounder J. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br. J. Urol. 81 (1998) 730-734
8. Comasseto J.V., Menezes P.H., Stefani H.A., Zeni G., and Braga A.L. Addition of hydrogen halides to acetylenic selenides. Synthesis of 1-halo-1-selenoalkenes. Tetrahedron. 52 (1996) 9687-9702
9. Coygreave I.A., Duddy S.K., Kass G.E.N., Thompson D., and Moldeus P. Studies on the anti-inflammatory activity of ebselen. Ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C?. Biochem. Pharmacol. 38 (1989) 649-656
10. Das R.K., Ghosh S., Sengupta A., Das S., and Bhattacharya S. Inhibition of DMBA/croton oil-induced two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate. Eur. J. Cancer Prev. 13 (2004) 411-417
11. Demir I., and Demirbag Z. Polisiklik aromatik hidrokarbonlarin biyolojik olarak parçalanmasi. Tr. J. Biol. 23 (1999) 293-302
12. Desai G.V., Casciano D., Feuers J.R., and Aidoo A. Activity profile of glutathione-dependent enzymes and respiratory chain complexes in rats supplemented with antioxidants and treated with carcinogens. Arch. Biochem. Biophys. 394 (2001) 255-264
13. Devillers I., Dive G., De Tollenaere C., et al. Imidazolopyrazinones as potential antioxidants. Bioorg. Med. Chem. Lett. 11 (2001) 2305-2309
14. Duffield-Lillico A.J., Reid M.E., Turnbull B.W., Combs G.F., Slate E.H., Fischbach L.A., Marshall J.R., and Clark L.C. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the nutritional prevention of cancer trial. Cancer Epid. Biomarkers Prev. 11 (2002) 630-639
15. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat. Res. 475 (2001) 123-139
16. El-Demerdash F.M. Antioxidant effect of vitamin E and selenium on lipid peroxidation, enzyme activities and biochemical parameters in rats exposed to aluminium. J. Trace Elem. Med. Biol. 18 (2004) 113-121
17. Fujii T., Fujii J., and Taniguchi N. Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role. Eur. J. Biochem. 268 (2001) 218-225
18. Gok Y., Cetinkaya E., Ozdemir I., Cetinkaya B., and Lappert M.F. Synthesis and characterisation of N-functionalized enetetramines, and their properties. Acta Chim. Slov. 51 (2004) 437-446
19. Hintz F.H. The many phases of selenium. Nutrition. World Equine Vet. Rev. 4 (1999) 9-22
20. Husain K., Scott B.R., Reddy S.K., and Somani S.M. Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol 25 2 (2001) 89-97
21. Ip C. Lessons from basic research in selenium and cancer prevention. J. Nutr. 128 (1998) 1845-1854
22. Lawrance R.A., and Burk R.F. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Research. Commun. 71 (1976) 952-958
23. Lipinski B. Rationale for the treatment of cancer with sodium selenite. Med. Hypoth. 64 4 (2005) 806-810
24. Liu J.Z., Zhang B.Z., and Milner J.A. Dietary selenite modifies glutathione metabolism and 7,12-dimethylbenz(a)anthracene conjugation in rats. J. Nutr. 124 (1994) 172-180
25. Lowry O., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurements with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
26. Luck H. Methods of Enzymatic Analysis (1963), Verlag Chemie, Academic Press, New York pp. 885-888
27. McCord J.M., and Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244 (1969) 6049-6055
28. Mruk D.D., Silvestrini B., Mo M., and Cheng Y.C. Antioxidant superoxide dismutase-a review: its function, regulation in the testis, and role in male fertility. Contraception 65 (2002) 305-311
29. Mugesh G., Mont W.W., and Sies H. Chemistry of biologically important synthetic organoselenium compounds. Chem. Rev. 101 (2001) 2125-2179
30. Nagar S., Zalatoris J.J., and Blanchard R.L. Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics 14 8 (2004) 487-489
31. Noyan, A., 1993. Fizyoloji, 8th ed. Meteksan, Ankara, Turkey.
32. Ozdemir I., Talas Z.S., Gul M., Ates B., Gok Y., Esrefoglu M., and Yilmaz I. Inhibition of DMBA induced rat mammary duct damage by novel synthetic organoselenium compounds. Exp. Anim. 55 5 (2006) 449-455
33. Parnham M., and Sies H. Ebselen: prospective therapy for cerebral ischaemia. Expert Opin. Inv. Drug. 9 (2000) 607-619
34. Perottoni J., Rodrigues O.E.D., Paixão M.W., Zeni G., Lobato L.P., Braga A.L., Rocha J.B.T., and Emanuelli T. Renal and hepatic ALA-D activity and selected oxidative stress parameter of rats exposed to inorganic mercury and organoselenium compounds. Food and Chem. Toxicol. 42 (2004) 17-28
35. Rayman M.P. The importance of selenium to human health. Lancet 356 (2000) 233-241
36. Saito I., Asano T., Sano K., Takakura K., Abe H., Yoshimoto T., Kikuchi H., Ohta T., and Ishibashi Y. Neuroprotective effect of an antioxidant, Ebselen, in patients with delayed neurological deficits after aneurismal subarachnoid hemorrhage. Neurosurgery 42 (1998) 269-277
37. Scheibmeir H.D., Christensen K., Whitaker S.H., Jegaethesan J., Clancy R., and Pierce J.D. A review of free radicals and antioxidants for critical care nurses. Intensive Crit. Care Nurs. 21 (2005) 24-28
38. Schrauzer G.N., White D.A., and Schneider C.J. Cancer mortality correlation studies. III. Statistical associations with dietary selenium intakes. Bioinorg. Chem. 7 (1977) 23-34
39. Shi H., Hudson L.G., and Liu K.J. Oxidative stress and apoptosis in metal ion-induced carcinogenesis. Free Radic. Biol. Med. 37 (2004) 582-593
40. Sun W. Reactive oxygen species and breast cancer carcinogenesis. Breast Cancer (2001) 77-222
41. Theodorus P., Akerboom M., and Sies H. Assay of glutathione, glutathione disulfide and glutathione mixed disulfides in biological samples. Methods Enzymol. 77 (1981) 373-383
42. Walther M., Holzhütter H., Kuban R.J., Wiesner R., Rathmann J., and Kühn H. The inhibition of mammalian 15-lipoxigenase by the anti-inflammatory drug ebselen: dual type mechanism involving covalent linkage and alteration of the iron ligand sphere. J. Pharmacol. Exp. Ther. 56 (1999) 196-203
43. Xia L., Nordman T., Olsson J.M., Damdimopoulos A., Björkhem-Bergman L., Nalvarte I., Eriksson L.C., Arnér E.S.J., Spyrou G., and Björnstedt M. The mammalian selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J. Biol. Chem. 278 (2002) 2141-2146
44. Yamagushi T., Sano K., Takakura K., Saito I., Shinohara Y., Asano T., and Yasuhara H. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Stroke 29 (1998) 12-17